Seeking Alpha

Mela Sciences (MELA) +83% premarket after the FDA issues an "approvable letter" for its medical...

Mela Sciences (MELA) +83% premarket after the FDA issues an "approvable letter" for its medical device that aims to help doctors more accurately diagnose melanoma. Previously the agency had called on the company to conduct a large new study of the MelaFind device, which already is approved for use in 27 European countries.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|